.grx-pd { /* no font-size: inherits the theme's body text size so this block matches surrounding UI on both Shopify and Zoey */ max-width: 760px; font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1a1a1a; line-height: 1.5; } .grx-pd__intro { font-size: 1em; margin: 0 0 1.75rem; } /* em = relative to inherited body size */ .grx-pd__intro strong { color: #0f0f0f; } /* auto-fit grid: cards reflow from 1 col on mobile to 2 on wider screens without media queries */ .grx-pd__grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(260px, 1fr)); gap: 14px; margin: 0 0 2rem; } .grx-pd__card { background: #f7f8fa; color: #3d3d3d; border-radius: 0; padding: 16px 18px; font-size: 1em; /* matches theme body text exactly */ transition: box-shadow .15s ease, transform .15s ease; } .grx-pd__card:hover { /* subtle lift signals these are discrete data points, not a plain list */ box-shadow: 0 4px 14px rgba(0,0,0,.06); } .grx-pd__card-title { /* larger + heavier than body so the mechanism reads first, body copy second */ display: block; font-size: 1em; font-weight: 700; color: #0f0f0f; margin: 0 0 .5rem; line-height: 1.5; } /* disclaimer intentionally low-contrast + small: legally present, visually de-emphasized */ .grx-pd__legal { border-top: 1px solid #e6e8ec; padding-top: 1.5rem; font-size: 1em; color: #6b7280; line-height: 1.55; } .grx-pd__legal p { margin: 0 0 .6rem; font-size: 1em;} .grx-pd__legal p:last-child { margin-bottom: 0; } PT-141 (Bremelanotide) is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH) that acts as an agonist at melanocortin receptors, particularly melanocortin 4 receptors (MC4R) within the central nervous system. Its mechanism involves modulation of neural pathways associated with sexual function and arousal, distinct from agents that target vascular processes. MC4R ActivationPT-141 demonstrates activation of MC4R, which is associated with supporting central nervous system pathways involved in sexual response. Hypothalamic Signaling ModulationPT-141 has been evaluated in peer-reviewed literature for its potential role in modulating hypothalamic signaling related to sexual behavior. Neural Circuit InfluencePT-141 exhibits effects on neural circuits that influence libido and desire through melanocortin receptor engagement. Central vs. Peripheral MechanismUnlike phosphodiesterase inhibitors, PT-141's activity is mediated via central neural mechanisms rather than peripheral vascular pathways. Preclinical Pharmacodynamic ProfilePT-141's pharmacodynamic profiles indicate central melanocortin receptor stimulation correlates with modulation of sexual function parameters in preclinical models. This product is intended for use by licensed healthcare providers in clinical settings. It is not intended for consumer sale. Buyer/doctor has determined and documented that the use of this product is appropriate for the patient based on the assessment of the patient's needs. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For professional use only.
Related
Related
Related